CILIQUE - Clinical Outsourcing + Contract Management + CRO Vendor Selection & ManagementCILIQUE - Clinical Outsourcing + Contract Management + CRO Vendor Selection & Management
CILIQUE supports you with expertise in Clinical Outsourcing and Vendor Selection. We provide consulting and seminars for the pharmaceutical industry.
  • CILIQUE
    • Services
    • Fair Deal
  • CRO Database
    • Search for CROs for your next Project
    • Data Upload for CROs
  • Seminars & Workshops
  • Jobs
  • News
  • Team
  • Contact Us
David or Goliath? – Is a Bigger CRO Better?
19 Okt 2016

David or Goliath? – Is a Bigger CRO Better?

The importance of midsized CROs in pharmaceutical and medical device development.

It’s no surprise to industry insiders that the largest pharmaceutical companies rely on the largest contract research organizations (CROs) for the lion’s share of their outsourced R&D. For example, in the first quarter of 2015, 34% of ICON’s total revenue (approximately $134 million of its estimated more than $500 million in annual sales) was with one client, presumably Pfizer; […] ICON, Parexel and PPD all have partnerships with Pfizer; Covance (LabCorp) has partnered with Eli Lilly, Bayer and Sanofi; and Quintiles has partnered with Takeda and Roche, to name a few.

The leading model for these relationships has increasingly become based on strategic partnerships offered by CROs. Strategic partnerships have largely supplanted project-by-project and preferred provider outsourcing methods, and for good reason. To remain profitable, sponsors are seeking greater productivity from their R&D investments, and this is often facilitated by highly integrated relationships spanning many years and multiple projects.

0
SHARES

But, what does all this mean for pre-revenue, small and midsized pharma/biotech and medical device sponsors?

In his interesting article, Jason Monteleone explains with well structured arguments, why mid sized CROs might also be a source of world-class technology, global footprint, deep expertise in specific therapeutic areas or technologies or the most talented scientists. 

(Foto: pcstratman - OT0917.David and Goliath/Flickr – CC BY-SA 2.0)

(Foto: pcstratman - OT0917.David and Goliath/Flickr – CC BY-SA 2.0)

 
Free online Training: Refocusing on Risk Mitigation in Starting Clinical Trials The Changing Role of the CRO and its Effect on Project Management

Related Posts

COVID-19: CRO – Financial Health Check

Blog, Blog

COVID-19: CRO – Financial Health Check

CRO Change Order received! – Why Worry?

Blog, Blog

CRO Change Order received! – Why Worry?

CILIQUE is attending Healthtech Invest Europe 2017

Blog

CILIQUE is attending Healthtech Invest Europe 2017

Weitere News

  • COVID-19: CRO – Financial Health CheckCOVID-19: CRO – Financial Health Check
    Juli 2, 2020
  • CRO Change Order received! – Why Worry?CRO Change Order received! – Why Worry?
    Mai 13, 2017
  • 3 Things to consider when running a Trial in a Med Device Start-up3 Things to consider when running a Trial in a Med Device Start-up
    Oktober 12, 2016
  • Are Change Orders a Necessary Evil?Are Change Orders a Necessary Evil?
    Oktober 12, 2016
  • How the Right Governance Structure can maximize your Partnership ValueHow the Right Governance Structure can maximize your Partnership Value
    Oktober 11, 2016
(c) 2016 CILIQUE UG
Impressum
Diese Website benutzt Cookies. Wenn du die Website weiter nutzt, gehen wir von deinem Einverständnis aus.OK